Metabolic risks neglected in schizophrenia and bipolar disorder
14 July 2009
| by Tony James
Weight gain and associated metabolic risks of psychotropic medication still fail to attract sufficient attention from psychiatrists, an international survey of patients with schizophrenia and bipolar disorder has concluded....
Want to read complete article? Please Sign in or Register.